New Products In Brief
This article was originally published in The Gray Sheet
Abbott’s Rx Herculink Elite
You may also be interested in...
FDA has ordered 21 current and former manufacturers of metal-on-metal total hip replacement systems to conduct post-market surveillance studies of their devices to assess metal toxicity risks.
Benefits, risks higher for mesh prolapse repair
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.